BlackDiamond Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BlackDiamond Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Sell	1,490 -250	-14%	-$33.8K	0.09%	200
2026 Q1	$222K	Sell	1,740 -30	-2%	-$3.75K	0.11%	183
2025 Q4	$223K	Sell	1,770 -363	-17%	-$41.6K	0.11%	183
2025 Q3	$214K	Buy	+2,133	New	+$192K	0.12%	163
2025 Q1	–	Sell	-2,443	Closed	-$220K	–	180
2024 Q4	$220K	Sell	2,443 -6	-0.2%	-$581	0.13%	150
2024 Q3	$246K	Sell	2,449 -153	-6%	-$15K	0.15%	143
2024 Q2	$247K	Sell	2,602 -27	-1%	-$2.42K	0.16%	122
2024 Q1	$249K	Sell	2,629 -19	-0.7%	-$1.76K	0.18%	127
2023 Q4	$234K	Buy	+2,648	New	+$197K	0.17%	126
2023 Q3	–	Sell	-2,516	Closed	-$209K	–	141
2023 Q2	$209K	Buy	+2,516	New	+$210K	0.18%	121

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BlackDiamond Wealth Management's XBI Position: Q2 2026 in Review

BlackDiamond Wealth Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 14% in Q2 2026, selling an estimated $33.8K and leaving 1,490 shares worth $236K. The position accounts for 0.09% of the portfolio, ranked #200.

BlackDiamond Wealth Management first reported a position in XBI in Q2 2023 and has held it in 10 quarters since. The position peaked at $249K in Q1 2024. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

BlackDiamond Wealth Management held 1,490 shares of State Street SPDR S&P Biotech ETF worth $236K as of Q2 2026.
BlackDiamond Wealth Management sold 250 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $33.8K.
State Street SPDR S&P Biotech ETF made up 0.09% of BlackDiamond Wealth Management's portfolio in Q2 2026, its #200 holding.
BlackDiamond Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 10 quarters since.
BlackDiamond Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $249K in Q1 2024.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on BlackDiamond Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.